In the US, Trandate (labetalol systemic) is a member of the drug class non-cardioselective beta blockers and is used to treat High Blood Pressure, Hypertensive Emergency, Mitral Valve Prolapse and Pheochromocytoma.
Ingredient matches for Trandate
Labetalol is reported as an ingredient of Trandate in the following countries:
Labetalol hydrochloride (a derivative of Labetalol) is reported as an ingredient of Trandate in the following countries:
- New Zealand
- South Africa
- United States